OssDsign AB (publ)

Stockholm Stock Exchange OSSD.ST

OssDsign AB (publ) Net Cash Used For Investing Activities for the year ending December 31, 2023: USD -12.24 K

OssDsign AB (publ) Net Cash Used For Investing Activities is USD -12.24 K for the year ending December 31, 2023, a 0.66% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.
  • OssDsign AB (publ) Net Cash Used For Investing Activities for the year ending December 31, 2022 was USD -12.32 K, a 99.78% change year over year.
  • OssDsign AB (publ) Net Cash Used For Investing Activities for the year ending December 31, 2021 was USD -5.71 M, a -166.53% change year over year.
  • OssDsign AB (publ) Net Cash Used For Investing Activities for the year ending December 31, 2020 was USD -2.14 M, a -6,075.24% change year over year.
  • OssDsign AB (publ) Net Cash Used For Investing Activities for the year ending December 31, 2019 was USD -34.69 K, a 95.97% change year over year.
Key data
Date Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure
Market news
SV Wall Street
Stockholm Stock Exchange: OSSD.ST

OssDsign AB (publ)

CEO Mr. Morten Henneveld
IPO Date May 24, 2019
Location Sweden
Headquarters Rapsgatan 23 A
Employees 41
Sector Technology
Industries
3D Printing Biotechnology Composite Materials Dental Care Medical Instruments Plastics
Description

OssDsign AB (publ) designs, manufactures, and sells implants and material technology for bone regeneration in Sweden, Germany, the United States, the United Kingdom, rest of Europe, and internationally. The company's products include OSSDSIGN cranial, an implant solution and related accessories for skull defect reconstruction in cranioplasty patients; and OSSDSIGN facial to treat post-traumatic skeletal deformities and congenital skeletal defects. It also offers OSSDSIGN Cranioplug for bone flap fixation and burr hole coverage; and OssDsign Catalyst, a nanosynthetic bone graft substitute that stimulates the formation of healthy bone tissue. The company was incorporated in 2011 and is headquartered in Uppsala, Sweden.

Similar companies

BONEX.ST

Bonesupport Holding AB (publ)

USD 30.85

-1.29%

StockViz Staff

February 5, 2025

Any question? Send us an email